New blood test could spot sepsis in newborns faster
NCT ID NCT07670624
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new biomarker called t6A to see if it can help doctors diagnose bacterial infections in newborn babies early. Researchers will measure t6A levels in 210 infants who need blood tests for suspected infection. The goal is to find a more accurate way to detect sepsis, which could lead to quicker treatment and fewer unnecessary antibiotics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
N6-threonylcarbamoyladenosine (t6A) biomarker test
What this could lead to
If successful, this could provide a faster, more accurate way to diagnose bacterial infections in newborns, potentially reducing unnecessary antibiotic use and improving outcomes.
What could go wrong
This is an early study with 210 participants and has not yet started recruiting. The biomarker may not prove reliable enough to replace current methods, and results may not apply to all newborns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••